FGF19 and cholestasis: Future strategies which combine the effects of the most powerful drugs to induce bicarbonate-rich choleresis, such as NorUDCA, with the most powerful drugs to suppress bile acid pool size, such as FGF19 mimetics or ASBT inhibitors, may therefore have real potential to heal cholestasis.